Treatment strategies for high-risk locally advanced prostate cancer.
about
The many faces of neuroendocrine differentiation in prostate cancer progressionTherapy-associated effects in the prostate gland.Current status of radical prostatectomy for high-risk prostate cancer.The early result of whole pelvic radiotherapy and stereotactic body radiotherapy boost for high-risk localized prostate cancerEnhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis.Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsManagement of high-risk localized prostate cancer.Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.Clinical significance of free-to-total prostate-specific antigen (PSA) ratio in advanced prostate cancer patients with PSA less than 0.1 ng/ml after hormone treatmentA Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology Practice.Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2.Menthol inhibits the proliferation and motility of prostate cancer DU145 cells.Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer.Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cellsTargeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells.Adherence to World Cancer Research Fund/American Institute for Cancer Research lifestyle recommendations reduces prostate cancer aggressiveness among African and Caucasian Americans.A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors.Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?Risks of Serious Toxicities from Intermittent versus Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study.STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.Radical prostatectomy in high-risk prostate cancer
P2860
Q26992049-67A57A6C-57C7-4BA2-9E6D-DA1439C0BD75Q34115527-458AE390-C230-4C69-8579-F96B7F616A9CQ34346841-3349066E-A01A-462B-8134-4654548CFC73Q34433023-20756F3A-D5F7-4948-ACB5-4D59C9B6081CQ34519820-D323636B-E3E2-449B-9615-5D09DD6A951CQ35380936-3BE39A86-710F-4761-8F55-75488E806399Q35503645-33097C0A-87A8-4F2D-BCB6-CFC5DC14B663Q35627417-EF91811F-3CA5-4B01-99CC-0D6D26136B0EQ35851975-B37952FA-73BB-401F-82F6-E456FE69EACEQ36480632-CE703828-8BB8-4A85-8EBF-FD1651A5DA73Q36623249-EA5361DC-9161-4A52-84C6-20D7433BFFD2Q38151298-A47D9FC5-CE3D-4969-A3DF-024B3D83E011Q39298392-A9EE978A-248B-445D-9034-096542917959Q39375869-FADCBE4E-C65D-4084-A3EF-6359175ADCB5Q41695208-F2AEE4BB-356A-4966-8D73-150AF141B930Q42265978-4CCE41EE-8DDA-4974-B6B2-4556BB9B3E10Q42650664-1FE390D3-D8DE-498C-8D7F-58F35732166AQ45502987-E6917E4C-1BA7-4355-8FE2-372CE421B7FCQ46956820-790AA707-E0DE-4F7B-B6D2-65F543E47C68Q48307140-5D6F9A25-2D57-4674-8103-FD66AF6C6927Q49204760-55AC9055-A137-426E-8C2A-EF8FA832A58EQ52684496-51ADB1A1-E639-4178-8FB0-CCDA21902E9AQ57131976-07A1FFEC-632E-4644-A2B8-D1BA2C884C1D
P2860
Treatment strategies for high-risk locally advanced prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment strategies for high-risk locally advanced prostate cancer.
@en
Treatment strategies for high-risk locally advanced prostate cancer.
@nl
type
label
Treatment strategies for high-risk locally advanced prostate cancer.
@en
Treatment strategies for high-risk locally advanced prostate cancer.
@nl
prefLabel
Treatment strategies for high-risk locally advanced prostate cancer.
@en
Treatment strategies for high-risk locally advanced prostate cancer.
@nl
P2860
P356
P1476
Treatment strategies for high-risk locally advanced prostate cancer.
@en
P2093
Howard M Sandler
Seth A Rosenthal
P2860
P2888
P356
10.1038/NRUROL.2009.237
P407
P577
2010-01-01T00:00:00Z